Stem cell Transplantation for Eradication of Minimal PAncreatic Cancer persisting after surgical Excision (STEM PACE Trial, ISRCTN47877138): study protocol for a phase II study

BACKGROUND: Pancreatic cancer is the third most common cancer related cause of death. Even in the 15% of patients who are eligible for surgical resection the outlook is dismal with less than 10% of patients surviving after 5 years. Allogeneic hematopoietic (allo-HSCT) stem cell transplantation is an...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitz-Winnenthal, Friedrich H, Schmidt, Thomas, Lehmann, Monika, Beckhove, Philipp, Kieser, Meinhard, Ho, Anthony D, Dreger, Peter, Büchler, Markus W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008264/
https://www.ncbi.nlm.nih.gov/pubmed/24612467
http://dx.doi.org/10.1186/1471-2407-14-168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008264/
https://www.ncbi.nlm.nih.gov/pubmed/24612467
http://dx.doi.org/10.1186/1471-2407-14-168

Ejemplares similares